CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT04704323 · RECRUITING
Trial details
- NCT number
- NCT04704323
- Sponsor
- Catapult Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2027-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.